Teva Pharmaceutical Industries Share Price Today
(NASDAQ: TEVA)

Name: Teva Pharmaceutical Industries Share Price Today (NASDAQ: TEVA) - Teva Pharmaceutical Industries Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Teva Pharmaceutical Industries share price is $15.9 & ₹1,382.81 as on 6 Mar 2025, 2.30 'hrs' IST

$15.9

▲

0.21

(1.34%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Teva Pharmaceutical Industries share price in Dollar and Rupees. Guide to invest in Teva Pharmaceutical Industries stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Teva Pharmaceutical Industries, along with analyst recommendations, forecasts, and comprehensive financials.

Teva Pharmaceutical Industries share price movements

Today's Low: $15.68
Today's High: $16.13
$15.90
1.38%
Downside
Day's Volatility :2.76%
Upside
1.4%
52 Weeks Low: $12.51
52 Weeks High: $22.80
$15.90
21.32%
Downside
52 Weeks Volatility :45.13%
Upside
30.26%

Teva Pharmaceutical Industries (TEVA) Returns

Period	Teva Pharmaceutical Industries Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.95%	2.1%	0.0%
6 Months	-14.87%	-4.1%	0.0%
1 Year	15.96%	2.2%	0.0%
3 Years	114.05%	11.8%	-11.6%

Teva Pharmaceutical Industries (TEVA) Key Statistics

in dollars & INR

Previous Close	$15.69
Open	$15.69
Today's High	$16.125
Today's Low	$15.68
Market Capitalization	$18.7B
Today's Volume	$3.4M
52 Week High	$22.8
52 Week Low	$12.51
Revenue TTM	$16.5B
EBITDA	$4.4B
Earnings Per Share (EPS)	$-1.45
Profit Margin	-9.91%
Quarterly Earnings Growth YOY	0.4%
Return On Equity TTM	-28.3%

How to invest in Teva Pharmaceutical Industries Stock (TEVA) from India?

It is very easy for Indian residents to invest directly in Teva Pharmaceutical Industries from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Teva Pharmaceutical Industries stock in both Indian Rupees (INR) and US Dollars (USD). Search for Teva Pharmaceutical Industries or TEVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Teva Pharmaceutical Industries or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Teva Pharmaceutical Industries shares which would translate to 0.055 fractional shares of Teva Pharmaceutical Industries as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Teva Pharmaceutical Industries, in just a few clicks!

Returns in Teva Pharmaceutical Industries (TEVA) for Indian investors in Rupees

The Teva Pharmaceutical Industries stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Teva Pharmaceutical Industries investment value today

Current value as on today

₹1,22,479

Returns

₹22,479

(+22.48%)

Returns from Teva Pharmaceutical Industries Stock

₹17,517 (+17.52%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Teva Pharmaceutical Industries (TEVA)

-20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Teva Pharmaceutical Industries Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Teva Pharmaceutical Industries

FMR Inc
7.15%
BlackRock Inc
4.41%
Clal Insurance Enterprises Holdings Ltd
3.40%
Ion Asset Management Ltd.
3.20%
MENORA MIVTACHIM HOLDINGS LIMITED
2.48%
Exor Investments (UK) LLP
2.37%

Analyst Recommendation on Teva Pharmaceutical Industries

Sell

0%Buy

33%Hold

66%Sell

Based on 9 Wall street analysts offering stock ratings for Teva Pharmaceutical Industries(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Teva Pharmaceutical Industries Stock (TEVA)

What analysts predicted

Upside of 50.29%

Target:

$23.90

Current:

$15.90

Insights on Teva Pharmaceutical Industries Stock (Ticker Symbol: TEVA)

Price Movement
In the last 3 years, TEVA stock has moved up by 110.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 4.33B → 4.22B (in $), with an average decrease of 2.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -845.0M → -217.0M (in $), with an average increase of 97.4% per quarter
TEVA vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 81.1%
TEVA vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 27.9%
Price to Sales
ForTEVA every $1 of sales, investors are willing to pay $1.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

TEVA Teva Pharmaceutical Industries Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$16.9B	↓ 10.43%
Net Income	$-999.0M	↓ 53.53%
Net Profit Margin	-5.92%	↑ 5.48%

	FY20	Y/Y Change
Revenue	$16.7B	↓ 1.36%
Net Income	$-4.0B	↑ 299.4%
Net Profit Margin	-23.95%	↓ 18.03%

	FY21	Y/Y Change
Revenue	$15.9B	↓ 4.68%
Net Income	$417.0M	↓ 110.45%
Net Profit Margin	2.63%	↑ 26.58%

	FY22	Y/Y Change
Revenue	$14.9B	↓ 6.0%
Net Income	$-2.4B	↓ 664.27%
Net Profit Margin	-15.77%	↓ 18.4%

	FY23	Y/Y Change
Revenue	$15.8B	↑ 6.17%
Net Income	$-559.0M	↓ 76.24%
Net Profit Margin	-3.53%	↑ 12.24%

	FY24	Y/Y Change
Revenue	$16.5B	↑ 4.4%
Net Income	$-1.6B	↑ 193.2%
Net Profit Margin	-9.91%	↓ 6.38%

	Q3 FY23	Q/Q Change
Revenue	$3.9B	↓ 0.72%
Net Income	$80.0M	↓ 109.27%
Net Profit Margin	2.08%	↑ 24.33%

	Q4 FY23	Q/Q Change
Revenue	$4.5B	↑ 15.77%
Net Income	$429.0M	↑ 436.25%
Net Profit Margin	9.63%	↑ 7.55%

	Q1 FY24	Q/Q Change
Revenue	$3.8B	↓ 14.02%
Net Income	$-139.0M	↓ 132.4%
Net Profit Margin	-3.63%	↓ 13.26%

	Q2 FY24	Q/Q Change
Revenue	$4.2B	↑ 8.61%
Net Income	$-845.0M	↑ 507.91%
Net Profit Margin	-20.3%	↓ 16.67%

	Q3 FY24	Q/Q Change
Revenue	$4.3B	↑ 4.08%
Net Income	$-437.0M	↓ 48.28%
Net Profit Margin	-10.09%	↑ 10.21%

	Q4 FY24	Q/Q Change
Revenue	$4.2B	↓ 2.38%
Net Income	$-217.0M	↓ 50.34%
Net Profit Margin	-5.13%	↑ 4.96%

	FY19	Y/Y Change
Profit	$7.5B	↓ 9.16%

	FY20	Y/Y Change
Profit	$7.7B	↑ 2.51%

	FY21	Y/Y Change
Profit	$7.6B	↓ 1.7%

	FY22	Y/Y Change
Profit	$7.0B	↓ 8.18%

	FY23	Y/Y Change
Profit	$7.6B	↑ 9.64%

	FY24	Y/Y Change
Profit	$8.1B	↑ 5.48%

	Q3 FY23	Q/Q Change
Profit	$1.9B	↑ 3.06%

	Q4 FY23	Q/Q Change
Profit	$2.4B	↑ 30.52%

	Q1 FY24	Q/Q Change
Profit	$1.8B	↓ 26.16%

	Q2 FY24	Q/Q Change
Profit	$2.0B	↑ 13.34%

	Q3 FY24	Q/Q Change
Profit	$2.1B	↑ 6.23%

	Q4 FY24	Q/Q Change
Profit	$2.1B	↓ 1.3%

	FY19	Y/Y Change
Operating Cash Flow	$538.0M	↓ 78.0%
Investing Cash Flow	$1.4B	↓ 27.38%
Financing Cash Flow	$-241.0M	↓ 92.81%

	FY20	Y/Y Change
Operating Cash Flow	$1.2B	↑ 126.02%
Investing Cash Flow	$863.0M	↓ 36.31%
Financing Cash Flow	$-1.9B	↑ 682.16%

	FY21	Y/Y Change
Operating Cash Flow	$798.0M	↓ 34.37%
Investing Cash Flow	$1.5B	↑ 76.48%
Financing Cash Flow	$-2.2B	↑ 15.23%

	FY22	Y/Y Change
Operating Cash Flow	$1.6B	↑ 99.25%
Investing Cash Flow	$656.0M	↓ 56.93%
Financing Cash Flow	$-1.5B	↓ 31.54%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$5.0M	↓ 98.46%
Investing Cash Flow	$184.0M	↓ 39.07%
Financing Cash Flow	$-576.0M	↑ 947.27%

Teva Pharmaceutical Industries Technicals Summary

Sell

Neutral

Buy

Teva Pharmaceutical Industries is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Teva Pharmaceutical Industries (TEVA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Teva Pharmaceutical Industries Ltd	-8.03%	-14.87%	15.96%	114.05%	76.69%
Intra-cellular Therapies, Inc.	3.42%	81.22%	98.76%	146.55%	588.92%
Haleon Plc Spon Ads	12.55%	3.39%	28.09%	43.99%	43.99%
Zoetis Inc.	-1.19%	-8.94%	-7.43%	-9.67%	30.97%
Neurocrine Biosciences Inc.	-24.64%	-6.68%	-14.47%	28.61%	27.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Teva Pharmaceutical Industries Ltd	30.17	NA	0.99	2.55	-0.28	0.05	NA	4.74
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.68	26.68	1.5	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.8	34.8	0.27	6.47	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Teva Pharmaceutical Industries Ltd	Sell	$18.7B	76.69%	30.17	-9.91%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.92%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$48.2B	43.99%	26.68	12.84%
Zoetis Inc.	Buy	$76.1B	30.97%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.3B	27.88%	34.8	14.49%

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Organization	Teva Pharmaceutical Industries
Employees	33892
CEO	Mr. Richard D. Francis
Industry	Health Technology

Management People of Teva Pharmaceutical Industries

Name	Title
Mr. Richard D. Francis	President, CEO & Director
Mr. Eliyahu Sharon Kalif	Executive VP & CFO
Mr. Mark Sabag	Executive Vice President of International Markets Commercial
Mr. Richard Gordon Daniell	Executive Vice President of European Commercial
Mr. Matthew Shields	Executive Vice President of Global Operations
Mr. Amir Weiss	Senior VP & Chief Accounting Officer
Mr. Christopher J. Stevo CFA	Senior Vice President of Investor Relations & Competitive Intelligence
Kathleen Veit	Senior Vice President, Global Compliance & Ethics Officer
Mr. David R. Mcavoy J.D.	Executive VP & Chief Legal Officer
Mr. Placid Jover	Executive VP & CHRO

Important FAQs about investing in TEVA Stock from India :

What is Teva Pharmaceutical Industries share price today?

Teva Pharmaceutical Industries share price today stands at $15.90, Open: $15.69 ; Previous Close: $15.69 ; High: $16.13 ; Low: $15.68 ; 52 Week High: $22.80 ; 52 Week Low: $12.51.

The stock opens at $15.69, after a previous close of $15.69. The stock reached a daily high of $16.13 and a low of $15.68, with a 52-week high of $22.80 and a 52-week low of $12.51.

Can Indians buy Teva Pharmaceutical Industries shares?

Yes, Indians can invest in the Teva Pharmaceutical Industries (TEVA) from India.

With INDmoney, you can buy Teva Pharmaceutical Industries at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Teva Pharmaceutical Industries at zero transaction cost.

How can I buy Teva Pharmaceutical Industries shares from India?

It is very easy to buy Teva Pharmaceutical Industries from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Teva Pharmaceutical Industries (TEVA) be purchased?

Yes, you can buy fractional shares of Teva Pharmaceutical Industries with INDmoney app.

What are the documents required to start investing in Teva Pharmaceutical Industries stocks?

To start investing in Teva Pharmaceutical Industries, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.